Eriksson O - Search Results

1

Identification of PDI Substrates by Mechanism-Based Kinetic Trapping.

Eriksson O, Stopa J, Furie B. Eriksson O, et al. Methods Mol Biol. 2019;1967:165-182. doi: 10.1007/978-1-4939-9187-7_10. Methods Mol Biol. 2019. PMID: 31069770

2

Thiol isomerase ERp57 targets and modulates the lectin pathway of complement activation.

Eriksson O, Chiu J, Hogg PJ, Atkinson JP, Liszewski MK, Flaumenhaft R, Furie B. Eriksson O, et al. J Biol Chem. 2019 Mar 29;294(13):4878-4888. doi: 10.1074/jbc.RA118.006792. Epub 2019 Jan 22. J Biol Chem. 2019. PMID: 30670593 Free PMC article.

3

The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa.

Eriksson O, Ramström M, Hörnaeus K, Bergquist J, Mokhtari D, Siegbahn A. Eriksson O, et al. J Biol Chem. 2014 Nov 21;289(47):32379-91. doi: 10.1074/jbc.M114.599332. Epub 2014 Oct 3. J Biol Chem. 2014. PMID: 25281742 Free PMC article.

4

Tissue Factor Noncoagulant Signaling: Mechanisms and Implications for Cell Migration and Apoptosis.

Åberg M, Eriksson O, Siegbahn A. Åberg M, et al. Among authors: eriksson o. Semin Thromb Hemost. 2015 Oct;41(7):691-9. doi: 10.1055/s-0035-1564046. Epub 2015 Sep 29. Semin Thromb Hemost. 2015. PMID: 26418256 Review.

5

Tissue factor/factor VIIa induces cell survival and gene transcription by transactivation of the insulin-like growth factor 1 receptor.

Åberg M, Eriksson O, Mokhtari D, Siegbahn A. Åberg M, et al. Among authors: eriksson o. Thromb Haemost. 2014 Apr 1;111(4):748-60. doi: 10.1160/TH13-07-0593. Epub 2013 Dec 12. Thromb Haemost. 2014. PMID: 24336871

6

Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer.

Eriksson O, Thulin Å, Asplund A, Hegde G, Navani S, Siegbahn A. Eriksson O, et al. BMC Cancer. 2016 May 31;16:341. doi: 10.1186/s12885-016-2375-1. BMC Cancer. 2016. PMID: 27246245 Free PMC article.

7

A stromal cell population in the large intestine identified by tissue factor expression that is lost during colorectal cancer progression.

Eriksson O, Asplund A, Hegde G, Edqvist PH, Navani S, Pontén F, Siegbahn A. Eriksson O, et al. Thromb Haemost. 2016 Nov 30;116(6):1050-1059. doi: 10.1160/TH16-04-0267. Epub 2016 Sep 22. Thromb Haemost. 2016. PMID: 27656710

8

Neutrophil CD64 expression - comparison of two different flow cytometry protocols on EPICs MCL and the Leuko64(™) assay on a Celldyn Sapphire haematology analyser.

Eriksson O, Douhan Håkansson L, Karawajczyk M, Garwicz D. Eriksson O, et al. Scand J Clin Lab Invest. 2015 Sep;75(5):428-33. doi: 10.3109/00365513.2015.1031690. Epub 2015 Apr 15. Scand J Clin Lab Invest. 2015. PMID: 25874478

9

Synthesis and biological evaluation of [¹¹C]AZ12504948; a novel tracer for imaging of glucokinase in pancreas and liver.

Jahan M, Johnström P, Nag S, Takano A, Korsgren O, Johansson L, Halldin C, Eriksson O. Jahan M, et al. Among authors: eriksson o. Nucl Med Biol. 2015 Apr;42(4):387-94. doi: 10.1016/j.nucmedbio.2014.12.003. Epub 2014 Dec 6. Nucl Med Biol. 2015. PMID: 25633247

10

Targeted resequencing and analysis of the Diamond-Blackfan anemia disease locus RPS19.

Martinez Barrio A, Eriksson O, Badhai J, Fröjmark AS, Bongcam-Rudloff E, Dahl N, Schuster J. Martinez Barrio A, et al. Among authors: eriksson o. PLoS One. 2009 Jul 9;4(7):e6172. doi: 10.1371/journal.pone.0006172. PLoS One. 2009. PMID: 19587786 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results